NCT01898195View on ClinicalTrials.gov

Improving Adherence to Smoking Cessation Medication Among PLWHA

NACompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Tobacco Use Cessation
Interventions
DRUG

Varenicline

Varenicline will be provided for three months.

BEHAVIORAL

Text Message

Text messages will be developed twice daily for three months

BEHAVIORAL

Adherence Behavioral Therapy

Seven Adherence Behavioral Therapy sessions will given over a three month period

Trial Locations (1)

10011

Spencer Cox Center for Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT01898195 - Improving Adherence to Smoking Cessation Medication Among PLWHA | Biotech Hunter | Biotech Hunter